Showing results (41-50 of 1,910) with videos related to
Sort By:
Pageof 191
AIDS Patient Care and Stds|October 9, 2007
Review: immunologic response to protease inhibitor-based highly active antiretroviral therapy: a reviewMark A Wainberg, Bonaventura ClotetVirologie (Montrouge, France)|January 9, 2020
Antiretroviral therapy with integrase inhibitors: more optionsFrançois Raffi, Mark A WainbergThe Journal of Antimicrobial Chemotherapy|December 17, 2009
Resistance profile of the new nucleoside reverse transcriptase inhibitor apricitabinePedro Cahn, Mark A WainbergViruses|August 29, 2014
Is resistance to dolutegravir possible when this drug is used in first-line therapy?Thibault Mesplède, Mark A WainbergAIDS Reviews|January 31, 2003
Might the M184V substitution in HIV-1 RT confer clinical benefit?Marco Petrella, Mark A WainbergJournal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2004
Resistance issues with new nucleoside/nucleotide backbone optionsMark A Wainberg, Dan TurnerDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Biochemical mechanisms involved in overcoming HIV resistance to nucleoside inhibitors of reverse transcriptaseMatthias Götte, Mark A. WainbergRetrovirology|December 21, 2012
Multiple choices for HIV therapy with integrase strand transfer inhibitorsFrancois Raffi, Mark A WainbergRetrovirology|March 27, 2015
The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNAWeijun Zhu, Rongyue Lei, Yann Le Duff, et al.Pageof 191